Le Revenu D'Intérêts Changement Date
Adma Biologics USD 376K 24K 2025-09
BioCryst Pharmaceuticals USD -0.13 3.59M 2024-12
Eli Lilly USD 65M 25M 2025-09
Insmed USD 765K 55K 2024-09
Karyopharm Therapeutics USD -0.15 0.11 2024-12
MacroGenics USD 1.53M 114K 2025-09
MannKind USD 1.64M 991K 2025-12
Merck USD 69M 27M 2025-12
Novavax USD 303K 27K 2021-12
Novo Nordisk DKK 3.42B 2.04B 2025-03
Pfizer USD 115M 51M 2026-03
Sanofi EUR 33M 81M 2025-12
Xencor USD 6.2M 338K 2025-12